Results 61 to 70 of about 5,241 (198)
Gene therapy is revolutionizing treatment paradigms for haemoglobinopathies, establishing a translational framework for disorders that impact red blood cell development. In their paper, Joshi et al. describe the preclinical and early clinical landscape of gene therapies for non‐haemoglobinopathy erythroid disorders and highlight common thematic ...
Gaurav Joshi +3 more
wiley +1 more source
BACKGROUND: Haemoglobinopathies can be quantitative (thalassemic syndromes) or qualitative (Hb variants). Haemoglobinopathies are the most common genetic defect globally.
Maha Tariq +5 more
doaj
ABSTRACT Introduction Patients with inherited bleeding and haemoglobin disorders face barriers to accessing timely dental care, increasing the risk of untreated oral disease and complications related to invasive procedures. Aim To evaluate the agreement between smartphone‐based asynchronous teledentistry and face‐to‐face examination for oral conditions,
Victor Cordeiro da Silva +7 more
wiley +1 more source
Background: Anaemia disproportionately affects tribal populations in India due to nutritional deficiencies, haemoglobinopathies, and limited healthcare access. Community-level data from tribal districts of Gujarat are lacking.
Mukundkumar Vaja +6 more
doaj +1 more source
Iron in haemoglobinopathies and rare anaemias
Iron overload in haemoglobinopathies and rare anaemias may develop from increased iron absorption secondary to hepcidin suppression, and/or from repeated blood transfusions.
John Porter
doaj +1 more source
ABSTRACT Introduction Red blood cell (RBC) biomechanics are key determinants of blood rheology, microcirculatory flow, and tissue oxygen delivery, yet remain underutilized in clinical practice because of methodological variability and limited standardization.
Baran Dastaran +3 more
wiley +1 more source
Haemoglobinopathies in Europe: health & migration policy perspectives [PDF]
BACKGROUND: Major haemoglobinopathies (MH), such as thalassaemia syndromes (Thal) and sickle cell disorders (SCD), are genetic defects associated with chronic anaemia and other complications.
Petrova-Benedict, Roumyana +6 more
core +1 more source
ABSTRACT Background Since the 1970s, more than 40 red blood cell–based formulas have been proposed to differentiate β‐thalassaemia trait (BTT) from iron deficiency (ID) and iron deficiency anaemia (IDA), the main causes of microcytic anaemia. In Germany, where haemoglobinopathies are rare in the autochthonous population but increasingly encountered due
Rafid Al‐Nabhan +2 more
wiley +1 more source
Screening for haemoglobinopathies on cord blood: laboratory and clinical experience.
Blood from the umbilical cord (cord blood) is screened for haemoglobinopathies in several neonatal screening programmes, as well as before banking as a source of stem cells.
Gulbis, Béatrice +2 more
core +1 more source
In anticoagulated atrial fibrillation, residual ischemic stroke risk persists despite guideline‐directed therapy. In this single‐center cohort, an enlarged index outpatient left atrial diameter independently predicted stroke and improved risk stratification when added to CHA2DS2‐VA (CHA2DS2‐VALa), supporting a simple, clinically implementable ...
Sefa Erdi Ömür +7 more
wiley +1 more source

